CA
NZ
UK
AU
IND
US
…
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public filings and disclosures for iTonic Holdings Ltd (NASDAQ: ITOC) are limited, so the company's core business and operating segments are not clearly documented in widely available sources. Available information does not identify specific long-term growth drivers, and investors should seek updated SEC filings or company communications to understand the revenue model and strategic priorities. The stock may appeal to investors willing to follow future operational disclosures and monitor management execution for evidence of scalable revenue and sustainable margins.
Primary investment risks include opaque business disclosure, thin trading and elevated volatility, uncertain revenue and profitability, and governance and execution risk common to small-cap listed companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -5.10M | -0.64M | -0.26M | 0.07M | 0.20M |
| Minority interest | 0.00M | 0.00M | 0.00M | - | - |
| Net income | -5.10M | -0.66M | -0.24M | 0.08M | 0.19M |
| Selling general administrative | 5.06M | 1.06M | 0.69M | 0.46M | 0.37M |
| Gross profit | 0.33M | 0.34M | 0.47M | 0.56M | 0.59M |
| Reconciled depreciation | 0.01M | 0.07M | 0.06M | 0.05M | 0.07M |
| Ebit | -5.19M | -0.64M | -0.26M | 0.07M | 0.20M |
| Ebitda | -5.17M | -0.57M | -0.20M | 0.13M | 0.27M |
| Depreciation and amortization | 0.01M | 0.07M | 0.06M | 0.05M | 0.07M |
| Operating income | -5.19M | -0.77M | -0.31M | 0.03M | 0.14M |
| Other operating expenses | 5.71M | 1.22M | 0.94M | 0.65M | 0.56M |
| Tax provision | 0.00M | 0.02M | -0.02M | -0.01M | 0.01M |
| Income tax expense | - | 0.02M | -0.02M | -0.01M | 0.01M |
| Total revenue | 0.52M | 0.45M | 0.63M | 0.68M | 0.70M |
| Total operating expenses | 5.51M | 1.12M | 0.78M | 0.53M | 0.45M |
| Cost of revenue | 0.20M | 0.10M | 0.16M | 0.12M | 0.11M |
| Total other income expense net | 0.09M | 0.13M | 0.05M | 0.04M | 0.07M |
| Net income from continuing ops | -5.10M | -0.66M | -0.24M | 0.08M | 0.19M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 9.10M | 6.72M | 1.62M | 1.40M | 1.33M |
| Intangible assets | 2.41M | - | - | - | - |
| Other current assets | 0.81M | 0.04M | 0.02M | 0.02M | 0.01M |
| Total liab | 0.97M | 0.54M | 1.32M | 0.85M | 0.38M |
| Total stockholder equity | 6.12M | 6.18M | 0.31M | 0.56M | 0.95M |
| Other current liab | 0.12M | 0.16M | 1.11M | 0.48M | 0.05M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -5.62M | -0.52M | 0.14M | 0.38M | 0.70M |
| Good will | 1.96M | 0.00M | - | - | - |
| Other assets | - | 0.00M | - | - | - |
| Cash | 1.49M | 6.16M | 0.23M | 0.07M | 0.14M |
| Total current liabilities | 0.46M | 0.54M | 1.21M | 0.68M | 0.14M |
| Current deferred revenue | 0.14M | 0.12M | 0.03M | 0.13M | - |
| Net debt | -1.35M | -5.91M | -0.07M | 0.15M | 0.16M |
| Short term debt | 0.14M | 0.25M | 0.05M | 0.05M | 0.06M |
| Short long term debt | 0.14M | 0.25M | - | - | - |
| Short long term debt total | 0.14M | 0.25M | 0.16M | 0.22M | 0.30M |
| Other stockholder equity | 11.70M | 6.66M | 0.12M | 0.12M | 0.12M |
| Total current assets | 4.09M | 6.68M | 0.53M | 0.72M | 1.02M |
| Short term investments | 1.44M | 0.00M | - | - | - |
| Net receivables | 0.30M | 0.36M | 0.23M | 0.48M | 0.77M |
| Inventory | 0.05M | 0.12M | 0.05M | 0.15M | 0.10M |
| Accounts payable | 0.07M | 0.01M | 0.02M | 0.01M | 0.02M |
| Accumulated other comprehensive income | 0.04M | 0.04M | 0.05M | 0.06M | 0.13M |
| Non currrent assets other | 0.60M | -0.00M | 0.85M | 0.46M | 0.02M |
| Non current assets total | 5.01M | 0.05M | 1.09M | 0.68M | 0.31M |
| Capital lease obligations | - | 0.00M | 0.16M | 0.22M | 0.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -1.40M | 0.00M | 0.00M | - | - |
| Total cashflows from investing activities | -1.35M | -0.00M | - | - | - |
| Net borrowings | -0.11M | 0.25M | 0.00M | 0.00M | 0.05M |
| Total cash from financing activities | -0.08M | 6.71M | 0.22M | 0.08M | -0.07M |
| Net income | -5.10M | -0.66M | -0.24M | 0.08M | 0.19M |
| Change in cash | -4.67M | 5.93M | 0.16M | -0.06M | 0.14M |
| Begin period cash flow | 6.16M | 0.23M | 0.07M | 0.14M | 0.13M |
| End period cash flow | 1.49M | 6.16M | 0.23M | 0.07M | 0.14M |
| Total cash from operating activities | -3.24M | -0.78M | -0.06M | -0.12M | 0.08M |
| Issuance of capital stock | 0.17M | 7.80M | 0.00M | 0.00M | - |
| Depreciation | 0.01M | 0.07M | 0.06M | 0.05M | 0.07M |
| Other cashflows from investing activities | 0.05M | - | - | - | - |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.40M | 0.00M |
| Change to inventory | 0.07M | -0.07M | 0.03M | -0.06M | 0.01M |
| Change to account receivables | -0.02M | -0.17M | 0.21M | -0.28M | 0.11M |
| Other cashflows from financing activities | -0.11M | -1.33M | 0.22M | 0.48M | -0.07M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -1.15M | -0.23M | 0.11M | -0.27M | -0.19M |
| Stock based compensation | 2.95M | 0.00M | 0.00M | - | - |
| Other non cash items | 3.00M | 0.02M | 0.02M | 0.02M | 0.01M |
| Free cash flow | -3.24M | -0.78M | -0.06M | -0.12M | 0.08M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| ITOC iTonic Holdings Ltd. |
-0.25 9.62% |
2.35 | - | - | 14.04 | 0.80 | 4.03 |
| ABT Abbott Laboratories |
4.07 3.83% |
110.27 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 |
| MDT Medtronic PLC |
- -% |
99.29 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 |
| SYK Stryker Corporation |
-0.06 0.02% |
306.81 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 |
| SEMHF Siemens Healthineers AG |
0.66 1.38% |
48.35 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 |
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jianfei Zhang | CEO & Chairman of the Board | 1972 |
| Ms. Simin Tan | Chief Financial Officer | 1995 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.09%
Communication Services
+0.21%
Consumer Cyclical
+1.14%
Consumer Defensive
+0.88%
Energy
-2.61%
Financial Services
+0.70%
Financials
+0.41%
Healthcare
-0.75%
Industrials
+0.35%
Real Estate
+0.57%
Technology
-1.17%
Utilities
+0.05%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...